Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - TOTAL LIABILITIES
Total Liabilities ANAB - AnaptysBio, Inc.
364 M
LAST VALUE
12.73%
2 YEAR CAGR
74.32%
5 YEAR CAGR
57.95%
10 YEAR CAGR